CorMedix Inc.
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapies for infectious and inflammatory diseases, with a focus on products like DefenCath® for bloodstream infections. The company actively advances its pipeline through clinical trials, regulatory submissions, strategic initiatives, and partnerships, aiming to address critical unmet medical needs and reduce health disparities.
Industries
Nr. of Employees
small (1-50)
CorMedix Inc.
Bridgewater, New Jersey, United States, North America
Products
Catheter-lock solution (antimicrobial + anticoagulant)
A catheter-lock formulation combining an antimicrobial small-molecule chemistry with an anticoagulant to reduce catheter-related bloodstream infections in patients with central venous catheters.
Catheter-lock solution (antimicrobial + anticoagulant)
A catheter-lock formulation combining an antimicrobial small-molecule chemistry with an anticoagulant to reduce catheter-related bloodstream infections in patients with central venous catheters.
Services
R&D collaboration and licensing
Collaborative development, in-licensing and co-development of antimicrobial therapeutics and device candidates, including sharing preclinical data and development expertise.
Commercial partnerships and market access support
Formation of commercial agreements with healthcare providers and operators, and execution of reimbursement and distribution strategies to enable inpatient and outpatient availability.
R&D collaboration and licensing
Collaborative development, in-licensing and co-development of antimicrobial therapeutics and device candidates, including sharing preclinical data and development expertise.
Commercial partnerships and market access support
Formation of commercial agreements with healthcare providers and operators, and execution of reimbursement and distribution strategies to enable inpatient and outpatient availability.
Expertise Areas
- Phase 3 clinical trial management
- Regulatory strategy and NDA/MAA submission management
- CMC development and GMP manufacturing scale-up
- Antimicrobial therapeutics and prevention of device-associated infections
Key Technologies
- Catheter-lock formulation (antimicrobial + anticoagulant)
- Small-molecule antimicrobial chemistry
- Antimicrobial device coating technologies
- Topical hydrogel formulation